Skip to main content

ABI's SOLiD Grant Program Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 31.
1. ABI to Grant SOLiD Services Under Competitive Grant Program (from Oct. 27)
2. Invitrogen, ABI Shareholders Approve Merger (from Oct. 28)
3. Responding to FDA, LabCorp Discontinues Offering OvaSure Test (from Oct. 27)
4. Zerhouni Confirms Kington to Take Over as NIH Acting Director (from Oct. 30)
5. Hedge Fund Ups Pressure on MDS, Urges Analytical Technologies Divestiture (from Oct. 30)
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.